Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

PURPOSE: We recently reported on a randomized, open-label, phase 3 trial comparing pemetrexed-cisplatin chemotherapy followed by gefitinib maintenance therapy (PC/G) with gefitinib monotherapy in patients with non-small cell lung cancer (NSCLC). Here, we report on a post hoc subgroup analysis of tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jin Hyoung, Ahn, Myung-Ju, Kim, Dong-Wan, Cho, Eun Kyung, Kim, Joo-Hang, Shin, Sang Won, Wang, Xin, Kim, Jong Seok, Orlando, Mauro, Park, Keunchil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843755/
https://www.ncbi.nlm.nih.gov/pubmed/26511807
http://dx.doi.org/10.4143/crt.2015.135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843755/
https://www.ncbi.nlm.nih.gov/pubmed/26511807
http://dx.doi.org/10.4143/crt.2015.135

Ejemplares similares